Review Article

Update on the Targeted Therapy of the Bladder Cancer

Bladder cancer was considered as immunogenic cancer many years ago since the detected response to BCG instillation in the bladder. Recently, utilization of check point inhibitors in malignancies is the new era in cancer immunotherapy.

Published 19 Oct, 2016


Commentary

Internal Mammary Nodal Irradiation: The Jury is Still Out!

In the current era of “minimal” and “personalized” multi-disciplinary management for breast cancer, the data from thousands of women participating in the Regional Nodal Irradiation (RNI) trials has opened up debate on several conflicting issues.

Published 19 Oct, 2016


Research Article

Bioinformatic Evaluation and Comparison of Parallel aSNP and aCGH Analyses of Myelodysplastic Syndromes Patients with Normal Karyotype

To study MDS bone marrow samples for tumor specific alterations two different microarray platforms, aSNP and aCGH have been widely used.

Published 19 Oct, 2016


Case Report

Factors Associated with Peritumoral Adhesions during Nephrectomy after Renal Mass Biopsy

Objectives: To analyze factors associated with peritumoral adhesions (PTAs) during nephrectomy performed after Renal Mass Biopsy (RMB).

Published 19 Oct, 2016


Review Article

Endocrine Disrupting Compounds and Prostate Cell Proliferation

Epidemiological, in vitro and animal studies have indicated that Endocrine Disrupting Compounds (EDCs) influence the normal growth and development of the prostate as well as development and progression of prostate cancer.

Published 18 Oct, 2016


Review Article

Relevance of Repeat Transurethral Resection of the Bladder for High Grade pTa Bladder Cancer: A Review

Repeat transurethral resection of the bladder (reTUR) is highly recommended for high risk non muscle invasive bladder cancer. The evidence are strong for high grade pT1 tumors, but scarce for high grade pTa.

Published 18 Oct, 2016


Case Report

Pancytopenia and Neuroendocrine Small Cell Carcinoma of the Bladder

Clinical Practice: Small cell neuroendocrine tumor of the bladder is a rare aggressive tumor with high metastatic potential. Despite aggressive multi-modal treatment, it has a high mortality rate.

Published 18 Oct, 2016


Review Article

Plasma Albumin Alterations in Gastrointestinal Cancer Patients

Albumin plays a prime role in most functional characteristics of plasma and immune state of organism. Patients with gastrointestinal cancer exhibit a poorly functioning immune system.

Published 18 Oct, 2016


Mini Review

Role of Echocardiography in the Assessment of Cancer Therapeutics–Related Cardiac Dysfunction: An Updated State-of-the-Art Review

In the last years, cardiotoxicity in patients treated with chemotherapy became one of the most urgent issues for cardiologists because cancer has become one of the most common diseases of this century.

Published 17 Oct, 2016


Case Report

Uterine Carcinosarcoma in A BRCA2 Mutation Carrier

Background: Uterine carcinosarcoma is one of the most aggressive uterine cancers, with 5-year survival for advanced stage disease of 30%. Currently, there is no optimal standard chemotherapy regimen for uterine carcinosarcoma and most patients suffer from disease recurrence.

Published 14 Oct, 2016


Short Review/Commentary

PIK3CA Gene Mutations in Major Gynecologic Cancers

Gynecologic malignancies posses' major threat in women, leading to cancer in their reproductive organs, there are five main types including cervical, ovarian, uterine, vaginal and vulvar [1].

Published 28 Sep, 2016


Case Report

Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) for the Whole Pelvis did not Lead to Significantly Higher Toxicity Rates than Prostate-Only IMRT in Prostate Cancer Patients

Purpose: To explore the controversy of including pelvic nodes in radical radiotherapy for prostate cancer with the adopted of precise advanced techniques of Intensity Modulated Radiotherapy (IMRT) and verified through image-guidance.

Published 28 Sep, 2016


Case Report

Appendix Insulin Secreting Neuroendocrine Tumor in a Diabetic Patient: A Challenging Diagnosis

Introduction: Tumor-induced hypoglycemia is a rare entity and it is mainly due to pancreatic insulinomas. Non-islet cell tumor hypoglycemia is really exceptional and ectopic insulin secretion has been previously suggested.

Published 28 Sep, 2016


Research Article

Hepatocellular Carcinoma - Review of Treatment Options with Percutaneous Ablative Therapies

Hepatocellular carcinoma is a cause of significant morbidity and mortality with many risk factors contributing to its development.

Published 28 Sep, 2016


Case Report

Isolated Drain Site Metastasis after Laparoscopic Radical Pancreatosplenectomy in Left-Sided Pancreatic Cancer

In spite of debates, minimally invasive radical distal pancreatosplenectomy is carefully thought to be safe and effective in well selected left-sided pancreatic cancer.

Published 28 Sep, 2016


Mini Review

Postoperative Pancreatic Fistulas Complicated by Haemorrhage: Diagnosis and Treatment

Objective: We sought to review our experience with postoperative pancreatic fistulas complicated with bleeding.

Published 28 Sep, 2016


Research Article

Salvage Robotic Prostatectomy after Brachytherapy

Introduction: Salvage radical prostatectomy, although still underused, is becoming a feasible treatment for young, healthy patients with biochemical progression after initial treatment with radiotherapy.

Published 28 Sep, 2016


Research Article

Treatment-Related MR Imaging Findings in Patients with Glioma after Radiotherapy, Chemotherapy, and Biological Therapy

Patients undergoing radiotherapy, chemotherapy, and biological therapy demonstrate treatmentrelated changes and characteristic magnetic resonance imaging findings.

Published 28 Sep, 2016


Research Article

Outcomes of Surgery in Elderly Patients with a Retroperitoneal Soft Tissue Sarcoma

Aim of this Study: To evaluate short and long term results after curative surgery for a retroperitoneal sarcoma (RPS) in elderly patients.

Published 28 Sep, 2016


Original Article

Cardiovascular Co-Morbidity and the Outcome after Myeloablative Hematopoietic Stem Cell Transplantation for Advanced Lymphoma

We evaluated cardiovascular-associated co-morbidities systematically in patients undergoing hematopoietic stem cell transplantation (HCT) for lymphoma. In this study, 101 lymphoma patients (41.3 ± 13.6 years) receiving salvage myeloablative HCT with high-dose conditioning treatments were recruited.

Published 24 Sep, 2016





SHARE THIS ARTICLE


Renowned Editors

MIT, John Hopkins University, Stanford University, University of Michigan...300+

Rapid Peer Review

We assure 20 days rapid peer review process

Open Access

Open Access is the free, immediate, online availability of novel research

High Visibility

Published articles are easy to find on google, google scholar and other databases